PAI Holdings LLC — FDA Class II (D-0589-2026)

PAI Holdings LLC is recalling a drug due to non-compliance with USP or OTC monograph standards. This recall is classified as a voluntary action. The specific geographic scope or quantity of the recall is not provided.

• •PAI Holdings LLC is recalling a drug for safety standard violations.
• •The product does not meet USP or OTC monograph requirements.
• •This is a voluntary recall classified as Class II.
• •Consumers should check their medicine cabinets for this product.

Consumers using this drug may face health risks due to non-compliance with safety standards. They should stop using the product immediately.